The KMT2C gene has mutations or deletions in many tumors, including leukemia, liver cancer, pancreatic cancer, gastric cancer, cholangiocarcinoma, ovarian cancer, and bladder transitional cell carcinoma [19, 20]. Here, KMT2C is linked to ovarian carcinoma.